Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Peritoneal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00461786
What this trial is testing

Single Agent Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cancer
Eli Lilly and Company 51
Early research (Phase 1)Study completedNCT01220154
What this trial is testing

Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer+1 more
David O'Malley 9
Testing effectiveness (Phase 2)Study completedNCT00671788
What this trial is testing

A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Gynecologic Oncology Group 35
Early research (Phase 1)Study completedNCT04630769
What this trial is testing

FT516 and IL2 With Enoblituzumab for Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube AdenocarcinomaPrimary Peritoneal Cavity Cancer
Masonic Cancer Center, University of Minnesota 3
Not applicableLooking for participantsNCT05236686
What this trial is testing

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group 94
Testing effectiveness (Phase 2)Temporarily pausedNCT04042116
What this trial is testing

Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor

Who this might be right for
Advanced Solid TumorGynecologic Cancer
Clovis Oncology, Inc. 227
Large-scale testing (Phase 3)Study completedNCT00028743
What this trial is testing

Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
NCIC Clinical Trials Group 819
Early research (Phase 1)Not Yet RecruitingNCT07674615
What this trial is testing

IMMU-132 in TROP-2 Overexpressed Advanced and Relapsed Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancersPrimary+1 more
Shanghai Gynecologic Oncology Group 19
Not applicableStudy completedNCT01826227
What this trial is testing

Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian TubePrimary Peritoneal
Memorial Sloan Kettering Cancer Center 5
Early research (Phase 1)Study completedNCT00091273
What this trial is testing

Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
University of Virginia 9
Testing effectiveness (Phase 2)Study completedNCT00072566
What this trial is testing

Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

Who this might be right for
Primary Peritoneal CarcinomaRecurrent Ovarian CarcinomaStage IV Ovarian Cancer
National Cancer Institute (NCI) 70
Testing effectiveness (Phase 2)WithdrawnNCT06393751
What this trial is testing

Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer

Who this might be right for
Platinum-Refractory Fallopian Tube CarcinomaPlatinum-Refractory Ovarian CarcinomaPlatinum-Refractory Primary Peritoneal Carcinoma+20 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00436215
What this trial is testing

Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer

Who this might be right for
Ovarian NeoplasmFallopian Tube CancerPrimary Peritoneal Cancer
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT00459290
What this trial is testing

Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 24
Testing effectiveness (Phase 2)UnknownNCT00003160
What this trial is testing

Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Theradex 100
Large-scale testing (Phase 3)Ended earlyNCT05092360
What this trial is testing

Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7)

Who this might be right for
Platinum-resistant Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Mural Oncology, Inc 456
Early research (Phase 1)Looking for participantsNCT07402915
What this trial is testing

Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal
AstraZeneca 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05456685
What this trial is testing

Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer

Who this might be right for
High Grade Ovarian CancerPrimary Peritoneal CancerFallopian Tube Cancer
AbbVie 125
Testing effectiveness (Phase 2)Study completedNCT01305213
What this trial is testing

Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
National Cancer Institute (NCI) 107
Next Page